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Abstract
Background: Emphysematous cholecystitis is a rare variant of acute cholecystitis with a high mortality rate. The
combination of emphysematous cholecystitis, liver abscess and pneumoperitoneum are even rarer. Herein we
present a case of emphysematous cholecystitis in a senile diabetic lady who had worsening hemodynamics while
undergoing hemodialysis.
Case presentation: A 64-year-old woman with history of type 2 diabetes mellitus and end stage renal disease with
regular hemodialysis presented to the emergency department with a 1-day history of sudden onset of lassitude
and hypotension during hemodialysis. The result of a computed tomography (CT)-scan revealed air encircling the
gallbladder, liver parenchymal and minimal pneumoperitoneal and liver abscess with no cholelithiasis. The patient
had received empirical antibiotics with piperacillin-tazobactam 2.25 g intravenous route every 6 h for 14 days and
cholecystectomy with surgical debridement and lead an uneventful postoperative hospital course. Escherichia coli
was demonstrated as well as blood culture and peritoneal fluid culture.
Conclusion: In a senile diabetic and dialysis patient, we should take emphysematous cholecystitis into consideration
once vague abdominal pain occurrs. Empirical antibiotic therapy and adequate surgical intervention should take place
as soon as possible.
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Background
Emphysematous cholecystitis (EC) is a rare life-
threatening form of acute cholecystitis representing be-
tween 1 and 3 % of acute cholecystitis presenting mainly
in male patients aged 50–70 years, and mostly occurring
in patients with diabetes mellitus, immunosuppressed
and peripheral vascular disease [1].
EC has been characterized clinically by the imaging
with gas in the gallbladder lumen, the gallbladder wall
and adjacent structure, and elsewhere in the biliary
tracts in the absence of an abnormal communication
with the gastrointestinal tract.
The gas may disseminate to subcutaneous tissue, as
well as to the peritoneal and retroperitoneal cavity. The
combination of emphysematous cholecystitis, liver ab-
scess and pneumoperitoneum are rarely seen. Dialysis
patients rarely develop such complications according to
the review of the literature from Pubmed [2].
Subhepatic abscess involved associated with emphyse-
matous cholecystitis is rare [3–5].
Emphysematous cholecystitis occurring in association
with a pneumoperitoneum is relatively rare [6, 7]. A re-
view of the literature from pubmed revealed 18 other
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cases of this combination and this is the first reported
case occurring during dialysis.
Herein we present a dialysis case with clinical image
composed of emphysematous cholecystitis, liver abscess
and pneumoperitoneum.
Case presentation
A 64-year-old woman with history of type 2 diabetes
mellitus and end stage renal disease with regular
hemodialysis presented to the emergency department
with a 1-day history of sudden onset of lassitude and
hypotension during hemodialysis. She complained of
fluctuating and persistent dull pain over the epigastric
area. The painful sensation could not be relieved by lying
down or adopting the decubitus position. She did not
have nausea, vomiting, tea color urine, clay-like stool,
muscle spasm or focal neurologic signs. She denied con-
tact with animals or travel to foreign countries in recent
days. On physical examination, the patient was actually
ill and had a body temperature of 37.3 °C, pulse rate of
110 beats per minute, respiratory rate of 40 times per
minute and blood pressure of 87/65 mmHg. The abdo-
men revealed right upper quadrant tenderness with
Murphy’s sign and muscular defense of the upper abdo-
men. In reviewing of the system, no diarrhea, no melena
or hematochezia, no dysuria, no hematuria, no flank
pain, no periumbilical and flank ecchymosis/petechiae
been found. In addition, the laboratory examinations re-
vealed leukocytosis (12800/uL) with a left shift (90.4 %
neutrophil), elevated C-reactive protein (44.92 mg/dL),
liver function impairment (aspartate aminotransferase
(AST) of 237 U/L and alanine aminotransferase (ALT) of
232 U/L) and mild jaundice (total bilirubin:1.48 mg/
dL). A plain radiography of the chest with the patient
in a supine position suggested the presence of a dilated
gallbladder with air in the lumen and wall (Fig. 1). The
result of a computed tomography (CT)-scan revealed
air encircling the gallbladder, liver parenchymal and
minimal pneumoperitoneal and liver abscess (Fig. 2a, b, c)
with no cholelithiasis. The patient had received empir-
ical antibiotics with piperacillin-tazobactam 2.25 g
intravenous route every 6 h for 14 days. The blood
Fig. 1 Plain-film radiography showing air in the lumen and wall of the enlarged gallbladder of a 64-year-old woman with abdomen pain and
shock while undergoing hemodialysis (arrows)
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culture yield Escherichia coli on the 4th admission day.
A general surgeon was consulted and cholecystectomy
and surgical debridement performed. The postoperative
course went smoothly without any complications . The
gallbladder was found to be necrotic. The culture of
the bile collected during the operation and the periton-
eal fluid collected from the pneumoperitoneum were
the same as the blood culture yielded Escherichia coli.
Pathologic analysis of the resected gallbladder disclosed
empyema with extensive transmural necrosis and neu-
trophils infiltration of the whole organ (Fig. 3). The pa-
tient had developed acute delirium status with response
to antipsychotic medication and active upper gastro-
intestinal tract bleeding with response to proton pump
inhibitor therapy during the latter hospital course. She
successfully recovered without any sequelae after ad-
equate antibiotic treatement.
Discussion
EC, also known as acute gaseous cholecystitis is patho-
physiologically different from acute or chronic cholecyst-
itis. Obstruction of the gallbladder neck secondary to
cholelithiasis induces acute and chronic cholecystitis. EC
frequently results from thrombosis or occlusion of the
cystic artery with ischemia necrosis of the gallbladder
wall with subsequent gallbladder necrosis and secondary
infection by gas-forming organisms. EC can be subclassi-
fied into 3 differente variants including gas in the gall-
bladder lumen, gallbladder wall and pericholecystic
tissues.
The mortality rate in EC is as high as 15 % compared
with 4 % in acute choleycystitis [8–11]. The most com-
mon symptoms in EC are right upper quadrant abdom-
inal pain. Fever, nausea and vomiting are also the main
clinical symptoms of emphysematous cholecystitis.
Fig. 2 a Computed tomography revealed air encircled the gall-bladder lumen as well as intramural and pericholecystic air pockets, with findings
pathognomonic for emphysematous cholecystitis. b Liver parenchymal destruction by air and partial liver abscess denoted. c Pneumoperitoneum
as denoted by white arrow
Fig. 3 Pathologic analysis of the resected gallbladder disclosed empyema with extensive transmural necrosis and neutrophils infiltration of the
whole organ. Mucosa slough with bacteria colonies been observed (arrow)
Liao et al. BMC Nephrology  (2016) 17:23 Page 3 of 8
However, the presenting symptoms of EC are sometimes
very vague and initially indistinquishable from those of
uncomplicated acute cholecystitis, frequently causing a
diagnostic dilemma, as in our patient initially masquer-
ading as hypotension while performing hemodialysis.
The symptoms may be even trivial in patients with dia-
betes mellitus and end-stage renal disease [2, 12].
We had conduct a systemic review from the series liter-
atures of Pubmed with the linkage between “emphysema-
tous cholecystitis”, “diabetes mellitus” and “hemodialysis”
which enclosed 23 papers, which include 29 cases of EC,
of which 21 cases have the cormobilities of diabetes, one
with regular CAPD and the other one received temporary
hemodialysis due to acute kidney injury with anuria re-
sulted from hemolytic uremia syndrome. (Table 1) To the
best of the author’s knowledge, concurrent EC, liver ab-
scess and pneumoperitoneum in a dialysis diabetic patient
has not been previously reported (Table 2). Diabetes usu-
ally provide an environment for submucosa thrombosis of
biliary tract and predispose patients to fulminant infec-
tions. The reason for delay in diagnosis probably involves
undetermined diabetes neuropathy, which sometimes
masks the symptoms of acute abdomen. Hyperglycemia
and ischemia environments in diabetic patients can lead
to reduced mobility of phagocytes in the areas of infection
and further reduce antimicrobial activity, making EC pos-
sible. Appropriate control of blood sugar levels can lower
the chance of bacterial overgrowth and associated severity
of the disease [11].
Chen et al. reported that end-stage renal disease was an
independent risk factor for acute cholecystitis. The inde-
pendent risk factors were older age, higher Charlson's
score, atrial fibrillation, severe liver disease, diabetes, and
dialysis modality. Haemodialysis patients had a higher risk
of acute cholecystitis than PD patients [12].
Another possible postulated mechanism in EC is the
fluctuating hemodynamic change during hemodialysis
compared with peritoneal dialysis [13]. Hypotension in
dialysis patient results from rapid reduction of blood
volume owing to ultrafiltration and decrease in extracel-
lular osmolarity during the dialysis session especially in
older and diabetic patient with coexisting illnesses, such
as cardiovascular diseases, which might contribute to
systemic hypoperfusion and further compromise visceral
circulation such as the cystic artery which lead to gall-
bladder ischemia and facilitates the proliferation of gas-
forming organisms and bacterial translocation in the
devitalized tissue with low oxygen saturation. The
hypotension episode in our patient can be overlooked
due to underlying bacteremia related septic shock may
mimic the presentation of dialysis process. Besides, the
inflammation and oxidants produced after ischaemia/re-
perfusion also impair the emptying of the gallbladder, in-
crease the residual volume, and reduce smooth muscle
Table 1 Review of the literature (1955–2015) of emphysematous cholecystitis with association without diabetes mellitus








1 54 M N/A − Yes Yes (Ce)/Yes B/C: C baratii/Liver abscess/- Huang et al. (2012)
[5]




3 47 M Alcoholism − − Yes (Ce)/Yes Bi/C: Escherichia Coli & Enterobacter
Femeral tissue culture: Escherichia




4 72 M N/A − − Yes (L)/Yes N/A Ise et al. (2002) [36]
5 67 F − − − Yes (Ce)/Yes B/C, Bi/C negative/Serum:





6 41 M ESRD secondary to Fabry’s with
regular CAPD; status post two
living related donor transplants;
Abdomen vessel calcifications
− − Yes (Ce)/Yes S/C: Clastridium difficile; P/C:
Clostridium perfringens/recent
massive UGIB/-
Mirza et al. (1997) [2]
7 64 M − − − Yes (Ce)/Yes Bi/C: Streptococcus group D-/ - Carvalho et al.
(1965) [38]
8 63 M − − N/A -/Yes N/A Tooms et al. (1955)
[39]
M male, F female, CA cancer, PAD peripheral arterial disease, CAD coronary artery disease, N/A unkown, −: none, SAH subarachnoidal hemorrhage, ESRD end-stage
renal disease, HUS hemolytic-uremic syndrome, OP operation, CAPD continous ambulatory peritoneal dialysis, HG hyperglycemia, FBG fasting blood glucose, GB
gallbladder, Ce cholecystectomy, Co cholecystostomy, Cd choledochotomy, PTGBD percutaneous transhepatic gallbladder drainage, Lo laparotomy, Lc laparoscopy,
Bi/C bile culture, B/C blood culture, S/C stool culture, P/C peritoneal fluid culture, APN acute pylonephritis, UGIB upper gastrointestinal tract bleeding
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Table 2 Review of the literature (1955–2015) of emphysematous cholecystitis with association with diabetes mellitus or dialysis
Number Age Gender Cormobilities Diabetes GB stone Operation/survival Bacteria source/Concurrent disease/Causative agents
other than bacteria
Author (year)
1 65 F CAD Yes − PTGBD & liver abscess
drainge/Yes
B/C: Clostridium perfringen/Liver abscess,
hemolysis/ -




2 85 M CAD Yes − Yes/Yes Bi/C: Clostridium perfringens/-/ - Mirrakhimov et al.
(2014) [20]
3 77 F Gastric CA Yes − Yes/Yes -/-/Chemotherapeutic agents Kuroda et al. (2013) [21]
Arterial sclerosis
4 73 M Nephropathy
Schizophrenia
Yes − Yes/Yes Bi/C: negative/Escherichia Coli related APN/- Ogawa et al. (2012) [22]
5 11 M Obesity Yes (type1) 1D − Yes (Lc)/Yes Bi/C: Enterococcus P/C: Escherichia Coli/Secondary
appendicitis/ -
Pal et al. (2011) [23]
6 82 F SAH HG while admission
(FBG:279mg/dL)
− Yes/Yes Bi/C: Clostridium species/Subarachnoidal
hemorrhage/ -
Uesaka et al. (2009) [24]
7 65 M Hypertension Yes multiple GB
stones
Yes (subtotal Ce & Co)
/Yes
Bi/C:toxin A of Clostridium difficile and Escherichia
Coli -/ -
Theodossis et al. (2008)
[25]
8 87 F Bedridden state Yes − PTGBD/- Bi/C & B/C & abdomen soft tissue culture:
Clostridium difficile/Renal failure; myonecrosis/-
Safioleas et al. (2007) [26]
9 32 M Yes − Yes (Ce)/No Bi/C: Escherichia Coli & Clostridium Welchii; Femeral
tissue culture: Escherichia Coli/Myonecrosis-
Safioleas et al. (2007) [26]
10 70 M Heart disease
Hyperlipidemia
Yes Multiple small GB
stones
Yes (Ce)/Yes Bi/C: Clostridium perfringens-/ - Shresth et al. (2007) [27]
11 68 M Hypertension CAD Type 1 − Yes (Ce)/Yes B/C: Clostridium perfringens and Corynebacteria-/ - Bernstein et al. (2007)
[28]
12 64 F Hypertension Yes Yes Yes (Ce)/Yes B/C: Salmonella derby Bi/C: Negative-/ - Moanna et al. (2006) [11]
Hypothyroidism
Anemia
13 62 M Alcoholism Yes − Yes (Ce)/Yes Bi/C: Klebsiella pneumonia-/ - Prieto Fernández et al.
(2004) [29]
Atrial fribrillation




15 42 M Recurrent UTI Yes Yes Yes (Ce)/Yes U/C & Bi/C : Negative /Emphysematous
pyelonephritis/-
Bhansali et al. (2004) [30]












Table 2 Review of the literature (1955–2015) of emphysematous cholecystitis with association with diabetes mellitus or dialysis (Continued)
17 70 M N/A Yes Yes (Mirizzi
syndrome)
Yes (Ce)/Yes N/A Ozkan et al. (2003) [32]
18 66 F Gastric CA post OP Yes − Yes (PTGBD; Ce and Cd)
/Yes
Bi/C: Clostridium perfingens & E. coli/
pneumobilia/-
Ohtani et al. (1996) [33]
Breast CA post OP
19 77 M − Yes − N/A N/A /Liver abscess- Matsura et al. (1995) [34]
20 66 M − Yes Yes Yes (Ce)/Yes N/A-/ - Carvalho et al. (1965) [35]
21 68 M − Yes N/A -/N/A - /-/ - Carvalho et al. (1965) [35]
M male, F female, CA cancer, PAD peripheral arterial disease, CAD coronary artery disease, N/A unkown, −: none, SAH subarachnoidal hemorrhage, ESRD end-stage renal disease, HUS hemolytic-uremic syndrome, OP operation, CAPD
continous ambulatory peritoneal dialysis, HG hyperglycemia, FBG fasting blood glucose, GB gallbladder, Ce cholecystectomy, Co cholecystostomy, Cd choledochotomy, PTGBD percutaneous transhepatic gallbladder drainage, Lo












contractility, which may increase the rate of acute
cholecystitis in HD patients [14]. Microinflammation in
hemodialysis patients also could lead to gut bacterial
translocation which further aggravats EC [15]. Chen at
al proposed that uremic toxin and increased oxidative
stress are both predisposing factors for causing in-
creased gallbladder mucosa inflammation and irritation
which further contributed to acute cholecystitis in
ESRD patients [12]. The pathogens responsible for the
gas formed in EC are usually anaerobes like Clostrid-
ium spp, or other microorganisms like Escherichia coli,
and Klebsiella spp,Proteus culgaris, Aerobacter aero-
genes, Staphylococcus, Streptococcus, and Salmonella
derby [11].
Our case demonstrates Escherichia coli in bile culture,
blood culture and peritoneal fluid, which suggested that
the hemodynamic instability during dialysis favored re-
sults from disseminated infection with septic shock.
Escherichia coli is a common bacteria present in the
gastrointestinal tract, especially in the colon and small
bowel. Bactereia tranlocate from duodenal to the biliary
tract when local aggressive factors take place, such as
peptic ulcer or hemodialysis in our patient [16]. CT
scanning of the abdomen is the most sensitive technique
for diagnosing emphysematous cholecystitis by presence
of gas within the gallbladder wall and lumen. The clin-
ical picture in our case demonstrated liver abscess ac-
companied with gas retention in the liver parenchyma,
gallbladder and biliary tract. Delay in diagnosis of EC
could lead to liver abscess formation [5, 15]. The pres-
ence of a concomitant pneumoperitoneum, which may
occur following gallbladder perforation, is rarely found.
Most patients with a concomitant pneumoperitoneum
are an emergent condition that requires emergency ex-
ploratory laparotomy, followed by cholecystectomy as in
our case. Another method of treatement, involves initial
percutaneous cholecystostomy with a strict intravenous
antibiotics regimen, followed by subsequent cholecystec-
tomy during second stage. In severely ill patients in par-
ticular, percutaneous cholecystostomy with broad –
spectrum antibiotics may be an alternative choice of
treatment.
There are scarce information about the treatment in
patients with EC in patients underwent hemodialysis
due to end stage renal diseas. Yeh had carried out that
laparoscopic cholecystectomy is safe for ESRD patients
with gallbladder lesions. Similar blood loss, conversion
rate, morbidity, mortality, and hospital stay were
achieved by applying laparoscopic cholecystectomy to
treat ESRD patients compared with the normal popula-
tions [17]. Gunay et al. had proposed that in a patient
underwent hemodiaysis with concurrent acute choley-
cystitis, cholecystectomy may be a better initial choice
compared with percutaneous cholecystostomy due to
higher success rate and lower morbidity and mortality
rate [18]. Gumus et al. suggested that in the manage-
ment of acute cholecystitis patients with chronic
hemodialysis states especially in poor surgical candidate,
percutaneous cholecystostomy may be the alternative
choice [19].
Conclusions
In conclusion,emphysematous cholecystitis is a rare
form of cholecystitis especially in dialysis patients which
could be fatal if delayed in diagnosis and progress to
pneumoperitoneal and liver abscess. In a senile diabetic
and dialysis patient, we should take emphysematous
cholecystitis into consideration once vague abdominal
pain and hypotension occurs in a patient underwent
hemodialysis. Empirical antibiotic therapy and adequate
surgical intervention should take place as soon as
possible.
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